These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Cohn DE; Ko E; Meyer LA; Wright JD; Temkin SM; Foote J; Jones NL; Havrilesky LJ Gynecol Oncol; 2017 Apr; 145(1):185-191. PubMed ID: 28258763 [No Abstract] [Full Text] [Related]
3. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice. Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256 [TBL] [Abstract][Full Text] [Related]
7. Electrical problems? Do you want a general contractor or an electrician? Partridge EE Gynecol Oncol; 2006 Nov; 103(2):379-80. PubMed ID: 17067881 [No Abstract] [Full Text] [Related]
8. Cost, Value, and Financial Hardship in Cancer Care: Implications for Pediatric Oncology. Parsons SK; Castellino SM; Yabroff KR Am Soc Clin Oncol Educ Book; 2018 May; 38():850-860. PubMed ID: 30231364 [TBL] [Abstract][Full Text] [Related]
9. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757 [TBL] [Abstract][Full Text] [Related]
10. Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology. Vistad I; Cvancarova M; Salvesen HB Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1286-92. PubMed ID: 22880840 [TBL] [Abstract][Full Text] [Related]
11. Should we centralise care for the patient suspected of having ovarian malignancy? Geomini PM; Kruitwagen RF; Bremer GL; Massuger L; Mol BW Gynecol Oncol; 2011 Jul; 122(1):95-9. PubMed ID: 21439618 [TBL] [Abstract][Full Text] [Related]
12. Assessing health-related quality of life in gynecologic oncology. Nordin AJ; Greimel E; Int J Gynecol Cancer; 2010 Nov; 20(8):1301. PubMed ID: 21051967 [No Abstract] [Full Text] [Related]
13. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice. Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946 [TBL] [Abstract][Full Text] [Related]
14. [Gynecological oncology in new millennium]. Shen K; Lang JH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):373-6. PubMed ID: 12974076 [TBL] [Abstract][Full Text] [Related]
15. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs. Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077 [TBL] [Abstract][Full Text] [Related]
16. Bone scintigraphy in oncology: an update with emphasis on efficacy and cost-effectiveness. Pauwels EK; Schütte HE; Arndt JW; van Langevelde A Diagn Imaging Clin Med; 1986; 55(6):314-20. PubMed ID: 3102147 [TBL] [Abstract][Full Text] [Related]
17. ACR appropriateness criteria follow-up of Hodgkin lymphoma. Ha CS; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP; Roberts KB; Shapiro R; Smith S; Terezakis SA; Winkfield KM; Younes A; Constine LS J Am Coll Radiol; 2014 Nov; 11(11):1026-1033.e3. PubMed ID: 25278496 [TBL] [Abstract][Full Text] [Related]
18. Interpreting the economic literature in oncology. Grusenmeyer PA; Wong YN J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940 [TBL] [Abstract][Full Text] [Related]
19. How do cost-effectiveness analyses inform reimbursement decisions for oncology medicines in Canada? The example of sunitinib for first-line treatment of metastatic renal cell carcinoma. Chabot I; Rocchi A Value Health; 2010; 13(6):837-45. PubMed ID: 20561332 [TBL] [Abstract][Full Text] [Related]
20. Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Tangjitgamol S; Anderson BO; See HT; Lertbutsayanukul C; Sirisabya N; Manchana T; Ilancheran A; Lee KM; Lim SE; Chia YN; Domingo E; Kim YT; Lai CH; Dali AZ; Supakapongkul W; Wilailak S; Tay EH; Kavanagh J; Lancet Oncol; 2009 Nov; 10(11):1119-27. PubMed ID: 19880066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]